These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6340253)

  • 1. Treatment of ischaemic stroke with prostacyclin.
    Gryglewski RJ; Nowak S; Kostka-Trabka E; Kusmiderski J; Dembinska-Kiec A; Bieron K; Basista M; Blaszczyk B
    Stroke; 1983; 14(2):197-202. PubMed ID: 6340253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin in ischemic stroke].
    Nowak S; Gryglewski R; Kostka-Trabkowa E; Bieroń K; Dembińska-Kieć A; Kuśmiderski J; Błaszczyk B; Olczyk E; Markowska E; Basista M
    Przegl Lek; 1983; 40(3):315-22. PubMed ID: 6191364
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke.
    Huczynski J; Kostka-Trabka E; Sotowska W; Bieron K; Grodzinska L; Dembinska-Kiec A; Pykosz-Mazur E; Peczak E; Gryglewski RJ
    Stroke; 1985; 16(5):810-4. PubMed ID: 3901421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute focal cerebral ischemia with prostacyclin.
    Awad I; Little JR; Lucas F; Skrinska V; Slugg R; Lesser RP
    Stroke; 1983; 14(2):203-9. PubMed ID: 6340254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.
    Hsu CY; Faught RE; Furlan AJ; Coull BM; Huang DC; Hogan EL; Linet OI; Yatsu FM
    Stroke; 1987; 18(2):352-8. PubMed ID: 3551212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia.
    Takamatsu H; Tsukada H; Watanabe Y; Cui Y; Kataoka Y; Hosoya T; Suzuki M; Watanabe Y
    Brain Res; 2002 Jan; 925(2):176-82. PubMed ID: 11792366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of prostacyclin (PGI2) in ischaemic stroke.
    Gryglewski RJ; Nowak S; Kostka-Trabka E; Bieroń K; Dembińska-Kieć A; Błaszczyk B; Kuśmiderski J; Markowska E; Szmatoła S
    Pharmacol Res Commun; 1982 Oct; 14(9):879-908. PubMed ID: 6757974
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in endogenous prostacyclin in the rat brain during clinical death and after resuscitation.
    Kapuściński A
    Neuropatol Pol; 1992; 30(2):127-32. PubMed ID: 1297927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial streptokinase in acute ischaemic stroke. A pilot study.
    Fitt GJ; Farrar J; Baird AE; Brooks M; Gilligan A; Donnan GA; Hennessy O
    Med J Aust; 1993 Sep; 159(5):331-4. PubMed ID: 8361430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
    Fitzgerald GA; Maas RL; Stein R; Oates JA; Roberts LJ
    Ann Intern Med; 1981 Sep; 95(3):319-22. PubMed ID: 7023309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental cerebral vasoconstriction: successful treatment of secondary cerebral ischaemia with intravenous prostacyclin.
    Grände PO; Lundgren A; Bjartmarz H; Cronqvist M
    Cephalalgia; 2010 Jul; 30(7):890-5. PubMed ID: 20647181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of prostacyclin in patients with ischemic stroke. A double-blind method II].
    Huczyński J; Gryglewski RJ; Kostka-Trabka E; Dembińska-Kieć A; Pykosz-Mazur E; Sotowska W; Grodzińska L; Peczak E; Bieroń K; Kedzior A
    Neurol Neurochir Pol; 1988; 22(4):299-304. PubMed ID: 3067105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous prostacyclin for ischemic ulcers in peripheral artery disease.
    Olsson AG
    Lancet; 1980 Nov; 2(8203):1076. PubMed ID: 6107693
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained Neurological Recovery After Stroke in Aged Rats Treated With a Novel Prostacyclin Analog.
    Yang C; DeMars KM; Alexander JC; Febo M; Candelario-Jalil E
    Stroke; 2017 Jul; 48(7):1948-1956. PubMed ID: 28588054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of prostacyclin (epoprostenol).
    Mikhailidis DP; Mikhailidis AM; Barradas MA; Dandona P
    Lancet; 1982 Oct; 2(8301):767. PubMed ID: 6125834
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(4):557-67. PubMed ID: 6193351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and analogues for acute ischaemic stroke.
    Bath PM; Bath FJ
    Cochrane Database Syst Rev; 2000; (2):CD000177. PubMed ID: 10796312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
    Pardy BJ; Lewis JD; Eastcott HH
    Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.